In summary, our study preliminarily presented relatively high value of peripheral memory PD-1+CD8 + T and PD-1+CD8+T/PD-1+CD4+T ratio in predicting response and prognosis to immunotherapy plus chemotherapy in patients with advanced gastric cancer. The gene discussed is CD4; the disease is gastric cancer.